By Ambar Warrick 

-- Oil prices fell further on Thursday as industry data signaled another big weekly build in U.S. crude inventories, while weak economic data and a potential rise in interest rates fanned growing fears over a looming recession. 

But losses in crude markets were limited as traders held out hope for a Chinese economic rebound this year. Reports from both the and the suggested that crude demand will hit new highs this year on the back of a Chinese recovery.

Data from the showed that U.S. oil inventories grew 7.6 million barrels last week, bucking expectations for a drop for a second consecutive week.

The figure usually heralds a similar trend in , which is forecast to show a draw of 593,000 barrels later in the day.

The API indicator came after data on Wednesday showed that U.S. and fell much more than expected in December. The readings ramped up concerns over a potential recession in the world’s largest oil consumer, which could weigh on overall crude demand this year.

fell 0.5% to $84.16 a barrel, while fell 0.7% to $78.86 a barrel by 20:30 ET (01:30 GMT). Both contracts slipped more than 1% on Wednesday following the weak U.S. economic readings.

High inflation readings from the and the also factored into fears of an economic slowdown, as did mixed signals on U.S. monetary policy from a slew of Federal Reserve speakers.

Members of the Fed largely supported more interest rate hikes, but offered differing messages on where U.S. interest rates will peak. 

But crude prices were still trading near annual peaks, having marked a strong rally over the past week on hopes that a Chinese reopening will drive a strong resurgence in demand this year.

The country began relaxing almost all of its strict anti-COVID measures since December, and recently reopened its borders for the first time in three years. 

Members of the International Monetary Fund recently in China after the reopening, which bodes well for the world’s largest crude importer.

But the country is still grappling with its worst-yet COVID-19 outbreak, which has brewed much uncertainty over the timing of such a recovery.